Leucopenia associated with metamizole: a case-control study
- PMID: 33378544
- DOI: 10.4414/smw.2020.14438
Leucopenia associated with metamizole: a case-control study
Abstract
Aims of the study: The aim of this study was to identify possible risk factors for the development of leucopenia associated with metamizole use.
Methods: A retrospective case-control study was performed. Cases of metamizole-associated leucopenia managed at a single centre (2005-2013) were characterised and compared with matched controls who took metamizole without developing complications.
Results: Fifty-seven cases and 139 controls were identified. Of the cases, 32 were postoperative and these were compared to age-, sex- and ward-matched postoperative controls (n = 64). The remaining cases (n = 25) were compared to sex-matched, non-postoperative controls (n = 75). The number of patients with a positive allergy history was higher among postoperative cases than controls (p = 0.004) as was the number with previous leucopenic episodes (p = 0.03). The prevalence of diagnosed hepatitis C infection was 9% among all cases compared with 1% among all controls (p = 0.005). The use of concomitant cytostatic agents (even at immunosuppressive doses) was significantly higher among non-postoperative cases than controls (p = 0.011). There was no association between renal function and the development of leucopenia.
Conclusions: A history of allergies, previous leucopenic episodes, hepatitis C infection and concomitant cytostatic agents are possible risk factors for leucopenia associated with metamizole use.
Similar articles
-
Leucopenia associated with metamizole: a case-control study.Swiss Med Wkly. 2017 May 24;147:w14438. doi: 10.4414/smw.2017.14438. eCollection 2017. Swiss Med Wkly. 2017. PMID: 28634963
-
Assessing potential risk factors for metamizole-induced leukopenia.Ther Adv Drug Saf. 2024 Sep 18;15:20420986241275255. doi: 10.1177/20420986241275255. eCollection 2024. Ther Adv Drug Saf. 2024. PMID: 39314989 Free PMC article.
-
Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.Eur J Intern Med. 2019 Oct;68:36-43. doi: 10.1016/j.ejim.2019.07.029. Epub 2019 Aug 3. Eur J Intern Med. 2019. PMID: 31383393
-
Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.Pain Pract. 2017 Mar;17(3):402-408. doi: 10.1111/papr.12467. Epub 2016 Jun 27. Pain Pract. 2017. PMID: 27346584 Review.
-
Metamizole (Dipyrone) and the Liver: A Review of the Literature.J Clin Pharmacol. 2019 Nov;59(11):1433-1442. doi: 10.1002/jcph.1512. Epub 2019 Aug 21. J Clin Pharmacol. 2019. PMID: 31433499 Review.
Cited by
-
Paediatric Agranulocytosis Associated with Metamizole Treatment.Paediatr Drugs. 2021 Jan;23(1):105-110. doi: 10.1007/s40272-020-00431-1. Epub 2020 Nov 28. Paediatr Drugs. 2021. PMID: 33247375
-
Who is Taking Care of Central American Immigrant Youth? Preliminary Data on Caregiving Arrangements and Emotional-Behavioral Symptoms Post-Migration.Child Psychiatry Hum Dev. 2021 Apr;52(2):217-224. doi: 10.1007/s10578-020-01002-8. Child Psychiatry Hum Dev. 2021. PMID: 32399585
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials